Oncology Grants
In continuation of CHF’s strong support of canine cancer research, the Oncology Research Program Area remains committed to innovative research that will aid in the discovery of advanced diagnostic technology and therapeutic target identification.
To make sense of the complexity of cancer, new approaches are needed to provide comprehensive characterization of tumors and other canine cancers. These approaches will likely require broad bioinformatic analyses, high throughput methodologies and systems biology tools.
Active Grants:
Previously Awarded Grants:
| 2217 | A Novel Mechanism to Regulate the Growth of Canine Hemangiosarcoma |
| 02237-A | Capturing Tumor Cells in Canine Blood |
| 02215 | A Cancer Vaccine for Canine Osteosarcoma |
| 01889-G | Innovations in Prevention, Diagnosis, and Treatment of Cancer - Goldens Lead the Way |
| 02171-MOU | Histiocytic Sarcoma in Bernese Mountain Dogs: Novel Approaches To Treatment |
| 01826 | A Novel Treatment for Brain Tumors Using a One Medicine Approach |
| 02244-A | Beyond Peto's Paradox with the Geriatric Peromyscus |
| 01689-A | Increasing the Effectiveness of Radiation Therapy in Treatment of Mast Cell Tumors |
| 02071 | Development of a Therapeutic Brain Tumor Vaccine |
| 02091-A | Differentiating between Localized and Disseminated Histiocytic Sarcoma in Bernese Mountain Dogs |
| 02093-A | Sequencing Histiocytic Sarcoma (HS) loci identified by Genetic Association studies in the Bernese Mountain Dog (BMD) |
| 01822 | Beyond the Genome: The Intersection of Genes and the Environment in Canine Cancer |
| 01843 | Further Investigation of the Genes Controlling Canine Leukemia to Properly Diagnose and Control the Disease |
| 01872-A | Using Ultrasound as a Cost Effective and Non-Invasive Technique for Early Diagnosis of Solid Tumors |
| 01426 | Personalized Medicine for the Treatment of Canine Mast Cell Tumors |
| 1633 | Novel Therapy for Melanoma, Lymphoma, Meningioma and Nephroblastoma |
| 01577 | Identifying the Genes Conferring Risk for Transitional Cell Carcinoma |
| 01557 | Narrowing the Search for the Genetic Basis of Histiocytic Malignancies |
| 01914-A | Defining the Genes That Contribute to the Development of Soft Tissue Sarcomas |
| 01683-A | Improving Resection of Tumors through Enhanced Imaging |
| 01861-A | Preventing Heart Damage during Chemotherapy through Early Detection of Cardiotoxicity |
| 01669-A | Determining the Role of Bacterial Infection in Complications after Chemotherapy |
| 01929-A | Arginine Dependence: Identification of Cancer's Achilles Heel |
| 01703-A | Enhancing Natural Anti-Tumor Immune Responses during Chemotherapy |
| 01912-A | Enhancing the Safety and Efficacy of Anti-Cancer Drugs in Dogs |
The AKC Canine Health Foundation funds research in 23 different Research Program Areas for the health of all dogs. These program areas enable the Foundation to create depth in our research portfolio and help us to be responsive to the health concerns of our constituents.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
